Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Butyraldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Butyraldehyde inhibits the expression of DME AS3MT |
[1] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Pyrrolizidine alkaloid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01582
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Pyrrolizidine alkaloid inhibits the drug-metabolizing activity of DME AS3MT |
[2] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen up-regulates the expression of DME AS3MT |
[3] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME AS3MT |
[4] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME AS3MT |
[5], [6] |
Urethane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Urethane inhibits the expression of DME AS3MT |
[7] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME AS3MT |
[8] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME AS3MT |
[9] |
K-7174 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 inhibits the expression of DME AS3MT |
[10] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Phenylmercuric acetate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00818
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Phenylmercuric acetate inhibits the expression of DME AS3MT |
[11] |
|
|
|
|
|
|